344 related articles for article (PubMed ID: 15082589)
1. Expression and localisation of matrix metalloproteinases and their natural inhibitors in fistulae of patients with Crohn's disease.
Kirkegaard T; Hansen A; Bruun E; Brynskov J
Gut; 2004 May; 53(5):701-9. PubMed ID: 15082589
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease.
von Lampe B; Barthel B; Coupland SE; Riecken EO; Rosewicz S
Gut; 2000 Jul; 47(1):63-73. PubMed ID: 10861266
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of the expression of metalloproteases and their inhibitors in resected crohn's disease and complicated diverticular disease.
Altadill A; Eiró N; González LO; Junquera S; González-Quintana JM; Sánchez MR; Andicoechea A; Saro C; Rodrigo L; Vizoso FJ
Inflamm Bowel Dis; 2012 Jan; 18(1):120-30. PubMed ID: 21438097
[TBL] [Abstract][Full Text] [Related]
4. Changes in matrix metalloproteinase (MMP) and tissue inhibitors of metalloproteinases (TIMP) expression profile in Crohn's disease after immunosuppressive treatment correlate with histological score and calprotectin values.
Mäkitalo L; Sipponen T; Kärkkäinen P; Kolho KL; Saarialho-Kere U
Int J Colorectal Dis; 2009 Oct; 24(10):1157-67. PubMed ID: 19652986
[TBL] [Abstract][Full Text] [Related]
5. Ramiprilate inhibits functional matrix metalloproteinase activity in Crohn's disease fistulas.
Efsen E; Saermark T; Hansen A; Bruun E; Brynskov J
Basic Clin Pharmacol Toxicol; 2011 Sep; 109(3):208-16. PubMed ID: 21535409
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteases and their inhibitors are produced by overlapping populations of activated astrocytes.
Muir EM; Adcock KH; Morgenstern DA; Clayton R; von Stillfried N; Rhodes K; Ellis C; Fawcett JW; Rogers JH
Brain Res Mol Brain Res; 2002 Apr; 100(1-2):103-17. PubMed ID: 12008026
[TBL] [Abstract][Full Text] [Related]
7. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
8. In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.
Bhuvarahamurthy V; Kristiansen GO; Johannsen M; Loening SA; Schnorr D; Jung K; Staack A
Oncol Rep; 2006 May; 15(5):1379-84. PubMed ID: 16596214
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of mRNA for matrix metalloproteinases-1 and -3 and tissue inhibitor of metalloproteinases-1 in intestinal biopsy specimens from patients with coeliac disease.
Daum S; Bauer U; Foss HD; Schuppan D; Stein H; Riecken EO; Ullrich R
Gut; 1999 Jan; 44(1):17-25. PubMed ID: 9862821
[TBL] [Abstract][Full Text] [Related]
10. Induction of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs correlates with outcome of acute experimental pseudomonal keratitis.
Ikema K; Matsumoto K; Inomata Y; Komohara Y; Miyajima S; Takeya M; Tanihara H
Exp Eye Res; 2006 Dec; 83(6):1396-404. PubMed ID: 16968651
[TBL] [Abstract][Full Text] [Related]
11. [Immunohistochemical localization of matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) in tuberculous pleuritis].
Hoheisel G; Sack U; Hui DS; Lai F; Chan KS; Choi CH; Schauer J; Tannapfel A
Pneumologie; 2004 May; 58(5):305-8. PubMed ID: 15162254
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases and their tissue inhibitors in the developing neonatal mouse uterus.
Hu J; Zhang X; Nothnick WB; Spencer TE
Biol Reprod; 2004 Nov; 71(5):1598-604. PubMed ID: 15240428
[TBL] [Abstract][Full Text] [Related]
13. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
[TBL] [Abstract][Full Text] [Related]
14. Abnormal expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in brain arteriovenous malformations.
Hashimoto T; Wen G; Lawton MT; Boudreau NJ; Bollen AW; Yang GY; Barbaro NM; Higashida RT; Dowd CF; Halbach VV; Young WL;
Stroke; 2003 Apr; 34(4):925-31. PubMed ID: 12649522
[TBL] [Abstract][Full Text] [Related]
15. Regulation of matrix metalloproteinases and their inhibitors in the left ventricular myocardium of patients with aortic stenosis.
Fielitz J; Leuschner M; Zurbrügg HR; Hannack B; Pregla R; Hetzer R; Regitz-Zagrosek V
J Mol Med (Berl); 2004 Dec; 82(12):809-20. PubMed ID: 15558223
[TBL] [Abstract][Full Text] [Related]
16. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor beta signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures.
Di Sabatino A; Jackson CL; Pickard KM; Buckley M; Rovedatti L; Leakey NA; Picariello L; Cazzola P; Monteleone G; Tonelli F; Corazza GR; MacDonald TT; Pender SL
Gut; 2009 Jun; 58(6):777-89. PubMed ID: 19201776
[TBL] [Abstract][Full Text] [Related]
18. Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: a precancerous potential?
Rath T; Roderfeld M; Graf J; Wagner S; Vehr AK; Dietrich C; Geier A; Roeb E
Inflamm Bowel Dis; 2006 Nov; 12(11):1025-35. PubMed ID: 17075343
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of matrix metalloproteinases in a model of T cell mediated tissue injury in the gut: analysis by gene array and in situ hybridisation.
Salmela MT; MacDonald TT; Black D; Irvine B; Zhuma T; Saarialho-Kere U; Pender SL
Gut; 2002 Oct; 51(4):540-7. PubMed ID: 12235077
[TBL] [Abstract][Full Text] [Related]
20. Granulocytes in coronary thrombus evolution after myocardial infarction--time-dependent changes in expression of matrix metalloproteinases.
Li X; de Boer OJ; Ploegmaker H; Teeling P; Daemen MJ; de Winter RJ; van der Wal AC
Cardiovasc Pathol; 2016; 25(1):40-6. PubMed ID: 26490693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
